Preventing HIV infection is crucial, especially for individuals at higher risk. Today, PrEP (Pre-Exposure Prophylaxis) is recognized as one of the most effective strategies. Ricovir EM is a widely used PrEP option due to its globally standardized formulation, affordability, and inclusion in trusted medical guidelines.
This article will guide you through everything you need to know about Ricovir EM—from what it is, how it works, benefits, side effects, real user experiences, to step-by-step instructions on starting PrEP at a clinic.
Ricovir EM is an oral medication for HIV prevention, also known as PrEP (Pre-Exposure Prophylaxis). It is taken once daily under medical supervision.
The formulation combines Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg), a widely recognized standard regimen included in international medical guidelines.
Manufactured by Mylan/Viatris, Ricovir EM is endorsed by the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), and Thailand’s national HIV prevention guidelines. It is among the most commonly prescribed PrEP options worldwide.
Ricovir EM is one of the most commonly used PrEP options because it is more affordable than the original brand, Truvada, while containing the same standard formulation: Emtricitabine and Tenofovir Disoproxil Fumarate.
It is also endorsed by major health authorities, including the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), providing strong evidence of its effectiveness and long-term use.
For individuals planning to use PrEP consistently, Ricovir EM offers a cost-effective solution, allowing continuous HIV prevention without causing a heavy financial burden.
Ricovir EM contains the standard FTC/TDF regimen, which has been supported by strong evidence from major clinical studies such as the iPrEx, Partners PrEP, and PROUD trials. These studies confirmed that consistent PrEP use can reduce the risk of HIV acquisition by more than 90%.
Because of this evidence, PrEP with FTC/TDF has been included in global guidelines by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). Thailand has also adopted the same regimen in its national HIV prevention strategy.
This scientific backing ensures that Ricovir EM is not only affordable but also clinically validated as an effective long-term option for HIV prevention.
Ricovir EM is recommended for individuals at higher risk of HIV infection, including those with multiple sexual partners, those who do not consistently use condoms, and serodifferent couples where one partner is HIV-positive and the other is not.
It is also suitable for individuals who use certain recreational drugs that increase HIV risk, as well as those seeking long-term HIV prevention under medical supervision.
However, the decision to start Ricovir EM should always follow a medical evaluation to ensure individual suitability and safety.
Before starting Ricovir EM, essential health checks are required to ensure both safety and effectiveness. Doctors typically recommend:
Ricovir EM must be taken correctly and consistently under medical guidance to maximize its effectiveness in HIV prevention.
Take one tablet daily at around the same time each day. If a dose is missed within 12 hours, take it as soon as remembered. If more than 12 hours have passed, skip the missed dose and continue with the next dose. Do not double up.
In some cases, Ricovir EM may be used around specific risk events following a special dosing schedule prescribed by a doctor. This method is not suitable for everyone and should only be done under medical supervision.
Individuals on PrEP should repeat HIV testing every 3 months, along with periodic kidney function checks and STI screenings. These follow-ups ensure safety and the ongoing effectiveness of PrEP use.
Ricovir EM is considered a safe medication that has been widely used for HIV prevention. Most side effects are mild and temporary, such as nausea, headache, or mild dizziness, which often resolve after continued use.
In some cases, Ricovir EM may affect kidney function or bone mineral density, which is why regular monitoring and follow-up tests are recommended as part of medical supervision.
If severe symptoms occur—such as reduced urination, unusual fatigue, or signs of an allergic reaction—the medication should be discontinued, and medical attention should be sought immediately.
Ricovir EM shares the same formulation as Tenof EM and Teno EM (Emtricitabine 200 mg + Tenofovir Disoproxil Fumarate 300 mg / FTC/TDF). Their effectiveness is equivalent, with the main differences being manufacturer and cost.
Compared to Truvada (the original brand), Ricovir EM is more affordable. Descovy (FTC/TAF) and TAF EM are newer formulations with potentially fewer side effects on kidneys and bones, but they are significantly more expensive.
PrEP Brand Comparison Table
|
Brand |
Formulation |
Manufacturer |
Price Range |
Note |
|---|---|---|---|---|
|
Ricovir EM |
FTC/TDF |
Mylan |
Affordable |
Standard generic |
|
Tenof EM |
FTC/TDF |
Hetero |
Similar |
Generic alternative |
|
Truvada |
FTC/TDF |
Gilead |
Higher |
Original brand |
|
Descovy |
FTC/TAF |
Gilead |
Very high |
Newer formula, selective use |
In general, Ricovir EM can be safely used with most medications, including hormone therapy and gender-affirming hormones, without reducing the effectiveness of either treatment. However, it is always important to inform your doctor about all medications you are taking before starting PrEP.
Certain drugs—such as other antiretrovirals, some anticonvulsants, or medications affecting kidney function—may require adjustments or closer monitoring. For this reason, medical consultation is strongly recommended before combining Ricovir EM with other medicines.
When used with hormonal contraceptives or gender-affirming hormones, research has shown no significant interaction, meaning both PrEP and hormone therapy remain effective when taken together.
Individuals taking Ricovir EM can consume alcohol, as no direct interaction reduces the drug’s effectiveness. However, excessive drinking should be avoided since it may cause missed doses, lowering PrEP protection.
Recreational drugs such as ketamine or methamphetamine do not directly interfere with Ricovir EM, but the risky behaviors often associated with drug use can significantly increase the risk of HIV and other sexually transmitted infections.
Therefore, PrEP with Ricovir EM should ideally be combined with responsible lifestyle choices—moderate alcohol intake, safe sex practices, and reduced drug-related risks—to maximize its protective benefits.
At Safe Clinic, starting PrEP with Ricovir EM is affordable and typically includes both the medication and essential health screenings before initiation.
Ricovir EM Package
The price before starting PrEP Ricovir EM at Safe clinic was 3,800 baht.
If you have any questions or need to inquire, you can inquire via LINE @safeclinicbkk or book an appointment
Many individuals who began PrEP with Ricovir EM reported that the process was straightforward: they underwent basic health checks, including HIV and kidney function tests, followed by a doctor’s prescription and guidance on how to take the medication correctly.
Most users mentioned experiencing mild side effects in the beginning, such as nausea or light dizziness, which usually resolved within a few days. After that, Ricovir EM did not interfere with their daily routines.
What stood out most was the sense of reassurance—users felt more confident knowing that with Ricovir EM, they had strong medical protection against HIV under professional supervision.
In Thailand, PrEP medications such as Ricovir EM should only be obtained through clinics or hospitals under medical supervision. This ensures proper health checks and safe follow-up care.
Daily PrEP (one pill per day) is the standard recommendation. In some cases, doctors may consider On-Demand PrEP depending on individual risk and suitability.
Research and real-world use show that Ricovir EM is highly safe, with most side effects being mild and temporary. However, regular check-ups every 3 months are recommended for ongoing safety.
Yes. HIV testing every 3 months is essential to confirm negative status and allow doctors to monitor PrEP use safely.
Ricovir EM is a PrEP medication based on the standard FTC/TDF formulation, supported by extensive research and included in guidelines from WHO, CDC, and Thailand’s Ministry of Public Health. It is affordable, widely prescribed, and suitable for individuals at higher risk of HIV infection.
However, starting PrEP should always be done under medical supervision. Health checks and personalized consultations ensure safe and effective use, providing reliable HIV prevention tailored to each individual.
If you want to book appointment or consult more.
You can booking from website or social media this bottom section